Výsledky vyhledávání - "Piperacillin"

Population Pharmacokinetics and Dosing Optimization of Piperacillin in Elderly Patients with Pneumonia in the Intensive Care Unit.

Autoři: Sun J Yang C Tang BH a další

Zdroj: Journal of clinical pharmacology [J Clin Pharmacol] 2025 Dec; Vol. 65 (12), pp. 1767-1776. Date of Electronic Publication: 2025 Aug 05.

Způsob vydávání: Journal Article

Informace o časopise: Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE

Výrazy ze slovníku MeSH: Anti-Bacterial Agents*/pharmacokinetics , Anti-Bacterial Agents*/administration & dosage , Anti-Bacterial Agents*/blood , Models, Biological* , Piperacillin*/pharmacokinetics , Piperacillin*/administration & dosage , Piperacillin*/blood , Pneumonia*/drug therapy , Pneumonia, Bacterial*/drug therapy, Humans ; Aged ; Male ; Female ; Intensive Care Units ; Aged, 80 and over ; Prospective Studies ; Monte Carlo Method ; Piperacillin, Tazobactam Drug Combination/pharmacokinetics ; Piperacillin, Tazobactam Drug Combination/administration & dosage ; Microbial Sensitivity Tests ; Dose-Response Relationship, Drug ; Middle Aged

Probability of pharmacokinetic/pharmacodynamic target attainment for different piperacillin/tazobactam dosing regimens in renally impaired patients in a non-intensive care unit setting.

Autoři: Dohmann E Hagel S Kurlbaum M a další

Zdroj: British journal of clinical pharmacology [Br J Clin Pharmacol] 2025 Nov; Vol. 91 (11), pp. 3070-3081. Date of Electronic Publication: 2025 Jun 29.

Způsob vydávání: Journal Article

Informace o časopise: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE

Výrazy ze slovníku MeSH: Anti-Bacterial Agents*/pharmacokinetics , Anti-Bacterial Agents*/administration & dosage , Anti-Bacterial Agents*/pharmacology , Piperacillin, Tazobactam Drug Combination*/pharmacokinetics , Piperacillin, Tazobactam Drug Combination*/administration & dosage , Renal Insufficiency*/therapy , Renal Insufficiency*/metabolism , Penicillanic Acid*/analogs & derivatives , Penicillanic Acid*/pharmacokinetics , Penicillanic Acid*/administration & dosage , Penicillanic Acid*/pharmacology, Humans ; Male ; Female ; Middle Aged ; Aged ; Models, Biological ; Microbial Sensitivity Tests ; Glomerular Filtration Rate ; Dose-Response Relationship, Drug ; Aged, 80 and over ; Adult ; Renal Dialysis ; Piperacillin/pharmacokinetics ; Piperacillin/administration & dosage

Piperacillin reaches high concentrations in bile and target tissues of the biliary system: an experimental study in pigs.

Autoři: Pontoppidan LL Bue M Houlind KC a další

Zdroj: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2025 Oct; Vol. 69 (10), pp. e0079225. Date of Electronic Publication: 2025 Aug 18.

Způsob vydávání: Journal Article

Informace o časopise: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

Výrazy ze slovníku MeSH: Bile*/metabolism , Anti-Bacterial Agents*/pharmacokinetics , Anti-Bacterial Agents*/pharmacology , Piperacillin*/pharmacokinetics , Piperacillin*/pharmacology , Biliary Tract*/metabolism , Biliary Tract*/drug effects, Animals ; Swine ; Microbial Sensitivity Tests ; Liver/metabolism ; Liver/drug effects ; Gallbladder/metabolism ; Gallbladder/drug effects ; Piperacillin, Tazobactam Drug Combination/pharmacokinetics ; Microdialysis ; Penicillanic Acid/analogs & derivatives ; Penicillanic Acid/pharmacokinetics ; Penicillanic Acid/pharmacology ; Common Bile Duct/metabolism ; Common Bile Duct/drug effects

Piperacillin/tazobactam clearance predicted by non-creatinine based estimates of GFR in critically ill adults.

Autoři: Barreto EF Chang J Rule AD a další

Korporace: Barreto EF Chang J Rule AD a další

Zdroj: International journal of antimicrobial agents [Int J Antimicrob Agents] 2025 Nov; Vol. 66 (5), pp. 107586. Date of Electronic Publication: 2025 Aug 07.

Způsob vydávání: Journal Article

Informace o časopise: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7913 (Electronic) Linking ISSN: 09248579 NLM ISO Abbreviation: Int J Antimicrob Agents Subsets: MEDLINE

Výrazy ze slovníku MeSH: Glomerular Filtration Rate* , Piperacillin, Tazobactam Drug Combination*/pharmacokinetics , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Anti-Bacterial Agents*/pharmacokinetics , Anti-Bacterial Agents*/therapeutic use, Humans ; Critical Illness ; Male ; Female ; Middle Aged ; Aged ; Creatinine/blood ; Adult ; Cystatin C/blood ; Piperacillin/pharmacokinetics

Comparison of 2-hour drip infusions of meropenem versus piperacillin/tazobactam for febrile neutropenia in pediatric patients.

Autoři: Kobayashi R Sano H Ishigaki R a další

Zdroj: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2025 Aug 06; Vol. 69 (8), pp. e0160824. Date of Electronic Publication: 2025 Jul 08.

Způsob vydávání: Journal Article; Randomized Controlled Trial; Comparative Study

Informace o časopise: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

Výrazy ze slovníku MeSH: Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/administration & dosage , Piperacillin*/therapeutic use , Piperacillin*/administration & dosage , Febrile Neutropenia*/drug therapy , Penicillanic Acid*/analogs & derivatives , Penicillanic Acid*/therapeutic use , Penicillanic Acid*/administration & dosage , Thienamycins*/therapeutic use , Thienamycins*/administration & dosage, Humans ; Meropenem ; Female ; Male ; Piperacillin, Tazobactam Drug Combination ; Child ; Child, Preschool ; Adolescent ; Prospective Studies ; Infusions, Intravenous ; Infant ; Immunoglobulins, Intravenous/therapeutic use ; Treatment Outcome

Simultaneous determination of piperacillin, metronidazole, and tazobactam in plasma by UPLC-MS/MS and application to a pharmacokinetic study in pediatric liver transplant patients.

Autoři: He C Ling S Jin Y a další

Zdroj: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2025 May 15; Vol. 1258, pp. 124605. Date of Electronic Publication: 2025 Apr 21.

Způsob vydávání: Journal Article

Informace o časopise: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101139554 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-376X (Electronic) Linking ISSN: 15700232 NLM ISO Abbreviation: J Chromatogr B Analyt Technol Biomed Life Sci Subsets: MEDLINE

Výrazy ze slovníku MeSH: Tandem Mass Spectrometry*/methods , Metronidazole*/blood , Metronidazole*/pharmacokinetics , Metronidazole*/chemistry , Liver Transplantation* , Tazobactam*/blood , Tazobactam*/pharmacokinetics , Piperacillin*/blood , Piperacillin*/pharmacokinetics , Anti-Bacterial Agents*/blood , Anti-Bacterial Agents*/pharmacokinetics , Penicillanic Acid*/analogs & derivatives , Penicillanic Acid*/blood , Penicillanic Acid*/pharmacokinetics, Humans ; Chromatography, High Pressure Liquid/methods ; Child ; Reproducibility of Results ; Linear Models ; Limit of Detection ; Child, Preschool ; Male ; Female ; Piperacillin, Tazobactam Drug Combination/blood ; Piperacillin, Tazobactam Drug Combination/pharmacokinetics ; Infant ; Adolescent ; Liquid Chromatography-Mass Spectrometry

Utilizing an Opportunistic Clinical Study and Population-Based Pharmacokinetic Models to Identify Rational Empiric Dosing Regimens for Piperacillin-Tazobactam in Critically Ill Patients.

Autoři: Reeder JA Creech CB Nation RL a další

Zdroj: Journal of clinical pharmacology [J Clin Pharmacol] 2025 Apr; Vol. 65 (4), pp. 452-465. Date of Electronic Publication: 2024 Dec 03.

Způsob vydávání: Journal Article

Informace o časopise: Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE

Výrazy ze slovníku MeSH: Anti-Bacterial Agents*/pharmacokinetics , Anti-Bacterial Agents*/administration & dosage , Piperacillin, Tazobactam Drug Combination*/pharmacokinetics , Piperacillin, Tazobactam Drug Combination*/administration & dosage , Models, Biological*, Humans ; Critical Illness ; Male ; Middle Aged ; Female ; Microbial Sensitivity Tests ; Prospective Studies ; Aged ; Pseudomonas aeruginosa/drug effects ; Adult ; Monte Carlo Method ; Piperacillin/pharmacokinetics ; Piperacillin/administration & dosage ; Infusions, Intravenous ; Pseudomonas Infections/drug therapy ; Aged, 80 and over

A National Retrospective Cohort Study Comparing the Effects of Cefepime Versus Piperacillin-Tazobactam on the Development of Severe Acute Kidney Injury in Patients With Septic Shock.

Autoři: Patanwala AE Nix DE Hills TE a další

Zdroj: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2025 Apr 30; Vol. 80 (4), pp. 770-776.

Způsob vydávání: Comparative Study; Journal Article; Multicenter Study; Observational Study

Informace o časopise: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

Výrazy ze slovníku MeSH: Acute Kidney Injury*/epidemiology , Acute Kidney Injury*/chemically induced , Anti-Bacterial Agents*/adverse effects , Anti-Bacterial Agents*/therapeutic use , Cefepime*/adverse effects , Cephalosporins*/adverse effects , Cephalosporins*/therapeutic use , Penicillanic Acid*/analogs & derivatives , Penicillanic Acid*/adverse effects , Penicillanic Acid*/therapeutic use , Piperacillin, Tazobactam Drug Combination*/adverse effects , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Shock, Septic*/drug therapy , Shock, Septic*/complications, Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Incidence ; Piperacillin/adverse effects ; Piperacillin/therapeutic use ; Retrospective Studies ; United States/epidemiology

First dose target attainment with extended infusion regimens of piperacillin and meropenem.

Autoři: Beijer G Swartling M Nielsen EI a další

Zdroj: Critical care (London, England) [Crit Care] 2025 May 22; Vol. 29 (1), pp. 208. Date of Electronic Publication: 2025 May 22.

Způsob vydávání: Journal Article

Informace o časopise: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9801902 Publication Model: Electronic Cited Medium: Internet ISSN: 1466-609X (Electronic) Linking ISSN: 13648535 NLM ISO Abbreviation: Crit Care Subsets: MEDLINE

Výrazy ze slovníku MeSH: Anti-Bacterial Agents*/administration & dosage , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/blood , Piperacillin*/administration & dosage , Piperacillin*/therapeutic use , Piperacillin*/blood , Thienamycins*/administration & dosage , Thienamycins*/blood , Thienamycins*/therapeutic use, Humans ; Meropenem/administration & dosage ; Female ; Male ; Middle Aged ; Aged ; Prospective Studies ; Infusions, Intravenous/methods ; Intensive Care Units/organization & administration ; Intensive Care Units/statistics & numerical data ; Penicillanic Acid/analogs & derivatives ; Penicillanic Acid/administration & dosage ; Penicillanic Acid/therapeutic use ; Piperacillin, Tazobactam Drug Combination ; Dose-Response Relationship, Drug ; Microbial Sensitivity Tests/methods ; Critical Illness/therapy ; Adult

Population pharmacokinetics of piperacillin-tazobactam in the plasma and cerebrospinal fluid of critically ill patients.

Autoři: Kumta N Heffernan AJ Cotta MO a další

Zdroj: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2025 Feb 13; Vol. 69 (2), pp. e0060124. Date of Electronic Publication: 2024 Dec 19.

Způsob vydávání: Journal Article; Research Support, Non-U.S. Gov't

Informace o časopise: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

Výrazy ze slovníku MeSH: Piperacillin, Tazobactam Drug Combination*/blood , Piperacillin, Tazobactam Drug Combination*/pharmacokinetics , Piperacillin, Tazobactam Drug Combination*/cerebrospinal fluid , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Anti-Bacterial Agents*/blood , Anti-Bacterial Agents*/cerebrospinal fluid , Anti-Bacterial Agents*/pharmacokinetics , Anti-Bacterial Agents*/therapeutic use , Cerebral Ventriculitis*/drug therapy , Cerebral Ventriculitis*/microbiology , Cerebral Ventriculitis*/blood, Humans ; Female ; Middle Aged ; Critical Illness ; Male ; Aged ; Piperacillin/blood ; Piperacillin/cerebrospinal fluid ; Piperacillin/pharmacokinetics ; Adult ; Tazobactam ; Microbial Sensitivity Tests

Model-informed dose optimization for prophylactic piperacillin-tazobactam in perioperative pediatric critically ill patients.

Autoři: Tan WR Irie K McIntire C a další

Zdroj: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2025 Mar 05; Vol. 69 (3), pp. e0122724. Date of Electronic Publication: 2025 Feb 06.

Způsob vydávání: Journal Article; Research Support, N.I.H., Extramural

Informace o časopise: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

Výrazy ze slovníku MeSH: Piperacillin, Tazobactam Drug Combination*/pharmacokinetics , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Anti-Bacterial Agents*/pharmacokinetics , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/administration & dosage, Humans ; Critical Illness ; Male ; Female ; Child ; Child, Preschool ; Infant ; Piperacillin/pharmacokinetics ; Piperacillin/therapeutic use ; Adolescent ; Creatinine/blood ; Microbial Sensitivity Tests ; Antibiotic Prophylaxis/methods

Pharmacokinetics of intravenous piperacillin/tazobactam among patients with peritoneal dialysis-associated peritonitis.

Autoři: Maneerot T Wongpraphairot S Lucksiri A a další

Zdroj: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis [Perit Dial Int] 2025 Jan; Vol. 45 (1), pp. 57-61. Date of Electronic Publication: 2024 Apr 26.

Způsob vydávání: Journal Article

Informace o časopise: Publisher: SAGE Publications Country of Publication: United States NLM ID: 8904033 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1718-4304 (Electronic) Linking ISSN: 08968608 NLM ISO Abbreviation: Perit Dial Int Subsets: MEDLINE

Výrazy ze slovníku MeSH: Peritonitis*/drug therapy , Peritonitis*/etiology , Peritonitis*/metabolism , Peritonitis*/microbiology , Piperacillin*/pharmacokinetics , Piperacillin*/administration & dosage , Anti-Bacterial Agents*/pharmacokinetics , Anti-Bacterial Agents*/administration & dosage , Penicillanic Acid*/analogs & derivatives , Penicillanic Acid*/pharmacokinetics , Penicillanic Acid*/administration & dosage , Peritoneal Dialysis*/adverse effects, Humans ; Male ; Middle Aged ; Female ; Prospective Studies ; Piperacillin, Tazobactam Drug Combination ; Aged ; Kidney Failure, Chronic/therapy ; Adult ; Infusions, Intravenous

Reliability of various antimicrobial susceptibility testing methods for piperacillin/tazobactam in challenging Escherichia coli isolates.

Autoři: Demirocak F Langerak D Yusuf E

Zdroj: Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2025 Mar; Vol. 41, pp. 211-215. Date of Electronic Publication: 2025 Jan 14.

Způsob vydávání: Journal Article

Informace o časopise: Publisher: Published by Elsevier Ltd. on behalf of International Society of Chemotherapy for Infection and Cancer Country of Publication: Netherlands NLM ID: 101622459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-7173 (Electronic) Linking ISSN: 22137165 NLM ISO Abbreviation: J Glob Antimicrob Resist Subsets: MEDLINE

Výrazy ze slovníku MeSH: Escherichia coli*/drug effects , Escherichia coli*/isolation & purification , Escherichia coli*/genetics , Piperacillin, Tazobactam Drug Combination*/pharmacology , Anti-Bacterial Agents*/pharmacology , Penicillanic Acid*/pharmacology , Penicillanic Acid*/analogs & derivatives, Microbial Sensitivity Tests/methods ; Microbial Sensitivity Tests/standards ; Reproducibility of Results ; Humans ; Piperacillin/pharmacology ; Escherichia coli Infections/microbiology ; beta-Lactamases/genetics

Prospective Piperacillin Lymphocyte Transformation Testing in Patients With Cystic Fibrosis Receiving Regular and Desensitization Courses of Piperacillin-Tazobactam.

Autoři: Whitaker P Gibson A Farrell J a další

Zdroj: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2025 Mar; Vol. 13 (3), pp. 594-609.e8. Date of Electronic Publication: 2024 Dec 12.

Způsob vydávání: Journal Article; Observational Study

Informace o časopise: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101597220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2201 (Electronic) NLM ISO Abbreviation: J Allergy Clin Immunol Pract Subsets: MEDLINE

Výrazy ze slovníku MeSH: Cystic Fibrosis*/immunology , Cystic Fibrosis*/drug therapy , Cystic Fibrosis*/therapy , Piperacillin, Tazobactam Drug Combination*/adverse effects , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Drug Hypersensitivity*/diagnosis , Drug Hypersensitivity*/therapy , Drug Hypersensitivity*/immunology , Desensitization, Immunologic*/methods , Anti-Bacterial Agents*/adverse effects , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/immunology , T-Lymphocytes*/immunology, Humans ; Male ; Female ; Adult ; Lymphocyte Activation ; Prospective Studies ; Adolescent ; Young Adult ; Piperacillin/therapeutic use ; Child ; Middle Aged

A Pooled Pharmacokinetic Analysis for Piperacillin/Tazobactam Across Different Patient Populations: From Premature Infants to the Elderly.

Autoři: Kong D Roberts JA Lipman J a další

Korporace: Kong D Roberts JA Lipman J a další

Zdroj: Clinical pharmacokinetics [Clin Pharmacokinet] 2025 Jan; Vol. 64 (1), pp. 107-126. Date of Electronic Publication: 2024 Dec 25.

Způsob vydávání: Journal Article

Informace o časopise: Publisher: Adis, part of Springer Science+Business Media Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE

Výrazy ze slovníku MeSH: Piperacillin, Tazobactam Drug Combination*/pharmacokinetics , Piperacillin, Tazobactam Drug Combination*/administration & dosage , Models, Biological* , Anti-Bacterial Agents*/pharmacokinetics , Anti-Bacterial Agents*/administration & dosage , Anti-Bacterial Agents*/blood , Penicillanic Acid*/pharmacokinetics , Penicillanic Acid*/analogs & derivatives, Humans ; Aged ; Adult ; Infant, Newborn ; Male ; Infant ; Middle Aged ; Female ; Monte Carlo Method ; Infant, Premature ; Child, Preschool ; Young Adult ; Child ; Piperacillin/pharmacokinetics ; Adolescent ; Age Factors

Assessment of Piperacillin-Tazobactam Population Pharmacokinetic Models in Neonates: An External Validation.

Autoři: Chaudhari BB Dilli Batcha JS Raju AP a další

Zdroj: European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2025 Jan; Vol. 50 (1), pp. 81-89. Date of Electronic Publication: 2024 Dec 16.

Způsob vydávání: Journal Article; Systematic Review; Validation Study

Informace o časopise: Publisher: Springer France Country of Publication: France NLM ID: 7608491 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2107-0180 (Electronic) Linking ISSN: 03787966 NLM ISO Abbreviation: Eur J Drug Metab Pharmacokinet Subsets: MEDLINE

Výrazy ze slovníku MeSH: Piperacillin, Tazobactam Drug Combination*/pharmacokinetics , Piperacillin, Tazobactam Drug Combination*/administration & dosage , Anti-Bacterial Agents*/pharmacokinetics , Anti-Bacterial Agents*/administration & dosage , Models, Biological*, Humans ; Infant, Newborn ; Intensive Care Units, Neonatal ; Piperacillin/pharmacokinetics ; Penicillanic Acid/pharmacokinetics ; Penicillanic Acid/analogs & derivatives

Continuous infusion of piperacillin/tazobactam optimizes intraoperative antibiotic exposure in patients undergoing elective pelvic exenteration surgery.

Autoři: Jackson D Ulldemolins M Liu X a další

Zdroj: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Dec 05; Vol. 68 (12), pp. e0111624. Date of Electronic Publication: 2024 Oct 31.

Způsob vydávání: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

Informace o časopise: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

Výrazy ze slovníku MeSH: Anti-Bacterial Agents*/pharmacokinetics , Anti-Bacterial Agents*/administration & dosage , Pelvic Exenteration*/methods , Piperacillin, Tazobactam Drug Combination*/administration & dosage , Piperacillin, Tazobactam Drug Combination*/pharmacokinetics, Female ; Humans ; Male ; Middle Aged ; Antibiotic Prophylaxis/methods ; Elective Surgical Procedures ; Infusions, Intravenous ; Microbial Sensitivity Tests ; Monte Carlo Method ; Piperacillin/pharmacokinetics ; Piperacillin/administration & dosage ; Prospective Studies

Predictive performance of multi-model approaches for model-informed precision dosing of piperacillin in critically ill patients.

Autoři: Schatz LM Greppmair S Kunzelmann AK a další

Zdroj: International journal of antimicrobial agents [Int J Antimicrob Agents] 2024 Oct; Vol. 64 (4), pp. 107305. Date of Electronic Publication: 2024 Aug 13.

Způsob vydávání: Journal Article; Multicenter Study

Informace o časopise: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7913 (Electronic) Linking ISSN: 09248579 NLM ISO Abbreviation: Int J Antimicrob Agents Subsets: MEDLINE

Výrazy ze slovníku MeSH: Critical Illness* , Anti-Bacterial Agents*/administration & dosage , Anti-Bacterial Agents*/therapeutic use , Drug Monitoring*/methods , Piperacillin*/administration & dosage , Piperacillin*/pharmacokinetics , Piperacillin*/therapeutic use, Humans ; Middle Aged ; Male ; Female ; Aged ; Algorithms ; Piperacillin, Tazobactam Drug Combination/administration & dosage ; Germany

Anaphylactic shock following a negative skin test for piperacillin-tazobactam: A case report.

Autoři: Cheng L Ning J

Zdroj: Asian journal of surgery [Asian J Surg] 2024 Oct; Vol. 47 (10), pp. 4641-4642. Date of Electronic Publication: 2024 Aug 10.

Způsob vydávání: Case Reports; Letter

Informace o časopise: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8900600 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0219-3108 (Electronic) Linking ISSN: 10159584 NLM ISO Abbreviation: Asian J Surg Subsets: MEDLINE

Výrazy ze slovníku MeSH: Anaphylaxis*/chemically induced , Anaphylaxis*/diagnosis , Piperacillin, Tazobactam Drug Combination*/adverse effects , Skin Tests* , Anti-Bacterial Agents*/adverse effects, Humans ; Piperacillin/adverse effects ; Male ; Female ; Penicillanic Acid/analogs & derivatives ; Penicillanic Acid/adverse effects ; Middle Aged

Reevaluating Piperacillin-Tazobactam Mortality-Reply.

Autoři: Chanderraj R Dickson RP Sjoding MW

Zdroj: JAMA internal medicine [JAMA Intern Med] 2024 Oct 01; Vol. 184 (10), pp. 1269.

Způsob vydávání: Letter

Informace o časopise: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print Cited Medium: Internet ISSN: 2168-6114 (Electronic) Linking ISSN: 21686106 NLM ISO Abbreviation: JAMA Intern Med Subsets: MEDLINE

Výrazy ze slovníku MeSH: Anti-Bacterial Agents*/therapeutic use , Piperacillin, Tazobactam Drug Combination*/therapeutic use, Humans ; Piperacillin/therapeutic use